HNSBF - Hansa Biopharma to Participate in Two Upcoming Investor Conferences
LUND, Sweden, Feb. 25, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's management team will participate in the following upcoming investor conferences:
- Cowen and Company's 40th Annual Health Care Conference in Boston on Monday, March 2, 2020, with a presentation at 4:10 PM EST/ 22:10 CET on the same day.
- The Carnegie Nordic Healthcare Seminar in Stockholm on Wednesday, March 4, 2020, with a presentation at 8:00 AM CET
A live webcast of the Cowen presentation will be available on the Events & Webcast page of the Company's website, www.hansabiopharma.com . A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.
Calendar 2020
Feb 27-28, 2020 |
Road Show Cowen, Chicago/Dallas |
Mar 2, 2020 |
Cowen Annual Health Care Conference, Boston |
Mar 4, 2020 |
Road Show Argot, New York City |
Mar 4, 2020 |
Carnegie Nordic Healthcare Seminar, Stockholm |
Mar 26, 2020 |
Kempen Expert Call with Prof. Mårten Segelmark on Anti-GBM |
Apr 2, 2020 |
Annual Report 2019 |
Apr 21-22, 2020 |
Kempen Life Sciences Conference, Amsterdam |
Apr 28, 2020 |
Interim Report Jan-Mar 2020 |
May 5, 2020 |
Annual General Meeting |
May 18, 2020 |
UBS Global Healthcare Conference, NYC |
May 19, 2020 |
RBC Global Healthcare Conference, NYC |
May 26, 2020 |
ABG Life Science Summit, Stockholm |
May 27, 2020 |
Ökonomisk Ugebrev Life Science Conference, Copenhagen |
Jul 16, 2020 |
Interimn Report Jan-Jul 2020 |
Sep 16-17, 2020 |
Bank of America Merill Lynch Global Healthcare Conf., London |
Oct 22, 2020 |
Interimn Report Jan-Sep 2020 |
CONTACT:
For further information, please contact:
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269
E-mail: klaus.sindahl@hansabiopharma.com
Rolf Gulliksen
Head of Corporate Communications
Hansa Biopharma
Mobile: +46 (0) 733-328 634
E-mail: rolf.gulliksen@hansabiopharma.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Hansa Biopharma to participate in two upcoming investor conferences |
SOURCE Hansa Biopharma AB